Country - Germany
Summary - Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form)
Deadline - Apr 30, 2026
MT reference number - 82029249
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 82029249
Document Type - Tender Notices
Description - Description: Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form)local title:: Arzneimittel mit dem Wirkstoff Rivaroxaban (ATC: B01AF01 - in der Wirkstärke 2,5 mg je abgeteilte orale Darreichungsform)type_of_procedure: Otherbidding_response_method: Not Available
Mt Ref Id - 82029249
Deadline - Apr 30, 2026
Similar Tenders :
Healthcare and Medicine